-- ブリタニア・インダストリーズ（NSE:BRITANNIA、BOM:500825）の連結帰属利益は、3月31日を期末とする会計年度第4四半期において、前年同期の56億インドルピーから67億8000万インドルピーに増加した。 同社は木曜日、インド証券取引所への提出書類の中で、1株当たり利益は前年同期の23.25ルピーから28.16ルピーに増加したと発表した。 会計年度第4四半期の営業収益は、前年同期の443億ルピーから472億ルピーに増加した。 同社の取締役会は、3月31日を期末とする会計年度について、額面1ルピーの普通株式1株当たり90.50ルピーの期末配当を推奨した。
Related Articles
Asia
Anhui Hwasu CFO Resigns
Anhui Hwasu (SHA:600935) said Bi Gang resigned as chief financial officer on Thursday due to a work transfer, according to a Friday filing with the Shanghai bourse.
$SHA:600935
Asia
Lotte Chemical Titan Incurs Wider Loss Despite 70% Higher Revenue
Lotte Chemical Titan (KLSE:LCTITAN) posted a wider first-quarter loss despite a 70% jump in revenue, according to a Thursday Malaysian bourse filing.Shares slid over 1% in Friday's midday trade.The loss widened as higher depreciation and financing costs from its Indonesia ethylene project weighed on earnings.Loss before tax rose to 230 million ringgit from 135 million ringgit a year earlier, even as revenue climbed to 2.53 billion ringgit from 1.49 billion ringgit.The higher revenue was driven by higher sales volumes from the Indonesia New Ethylene project that began commercial operations in October 2025.The group reported EBITDA of 150 million ringgit, compared with a negative EBITDA of 38 million ringgit a year earlier, while plant utilization improved to 61% from 46%.Lotte Chemical Titan said ongoing geopolitical tensions in the Middle East, particularly the Iran war, continue to create uncertainty in the global petrochemical market.
$KLSE:LCTITAN
Research
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Axon Enterprise, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We decrease our 12-month target price by $92 to $693, or 65.0x our 2027 EPS estimate, a discount relative to AXON's average forward P/E of 92.7x (during the trailing-12-month period). We trim our EPS estimates for 2026 by $0.16 to $7.78 and 2027's by $0.12 to $10.66. AXON's fundamental strength remains compelling as the company extends its competitive moat through an integrated ecosystem that combines hardware, cloud software, and AI capabilities. With 30%+ revenue growth for nine consecutive quarters, AXON is capitalizing on a $159 billion TAM while penetrating less than 15% of its core U.S. market. Multiple growth drivers are accelerating simultaneously: AI Era Plan bookings surged 140% Y/Y with near-universal adoption among large agencies; Dedrone counter-drone revenue jumped 300% Y/Y; and international revenue doubled, reaching 20% of total sales. Axon's 125% net revenue retention and $14.3 billion in future contracted bookings (+44% Y/Y) underscore strong visibility.
$AXON